Trinity Biotech (Trinity Biotech) Price-to-Tangible-Book : (As of Apr. 28, 2024)

View and export this data going back to 1995. Start your Free Trial

What is Trinity Biotech Price-to-Tangible-Book?

As of today (2024-04-28), Trinity Biotech's share price is $1.83. Trinity Biotech's Tangible Book per Share of Sep. 2023 for the quarter that ended in Sep. 2023 was $-4.40. Hence, Trinity Biotech's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Trinity Biotech's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Trinity Biotech's highest Price to Tangible Book Ratio was 240.57. The lowest was 5.01. And the median was 8.13.

TRIB's Price-to-Tangible-Book is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 2.4
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Trinity Biotech's share price is $1.83. Trinity Biotech's Book Value per Sharefor the quarter that ended in Sep. 2023 was $-2.29. Hence, Trinity Biotech's P/B Ratio of today is .

Trinity Biotech Price-to-Tangible-Book Historical Data

The historical data trend for Trinity Biotech's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trinity Biotech Price-to-Tangible-Book Chart

Trinity Biotech Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Tangible-Book

Get a 7-Day Free Trial

Trinity Biotech Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Trinity Biotech's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, Trinity Biotech's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Trinity Biotech's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Trinity Biotech's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Trinity Biotech's Price-to-Tangible-Book falls into.

Trinity Biotech Price-to-Tangible-Book Calculation

Trinity Biotech's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2023 )
	=	1.83	/	-4.404
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Trinity Biotech Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Trinity Biotech's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Trinity Biotech (Trinity Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (NAS:TRIB) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

TRBA:Germany

Address

IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8

Website

https://www.trinitybiotech.com

Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.